
Workforce Shortage in Rheumatology Best Addressed on All Fronts
In this video, rheumatologist Vaneet Kaur Sandhu, M.D., addresses the workforce shortage in rheumatology. It should be addressed on all fronts, she says. If the workforce shortage doesn't turnaround patients in underserved areas will continue to be treated by physicians, albeit well-intended physicians, with little to no experience in rheumatic disease. Learn more in this interview.
This week's featured guest is Vaneet Kaur Sandhu, M.D., a rheumatologist with Loma Linda University Medical Center in California.
Dr. Sandu is a member of the American College of Rheumatology communications and marketing committee and is the author of a paper published online last fall in
"People just need to know what rheumatology is," Dr. Sandu said.
If the workforce shortage doesn't turn around, she says, patients in underserved areas will continue to be treated by physicians―albeit well-intended physicians―who have no experience with rheumatic disease. Patient outcomes in these cases may not always be ideal, Dr. Sandhu said.
"Advocate, advocate, advocate," she says. "One of the big things is social accountability and the concept of medical education programs being the key for encouraging, educating, and inducing advocacy in your learners. It's just so important. If a learner is not pushed to do research or serve, they're not going to know. I think it really starts in medical education."
This week's video also includes a recap of recent headlines from Rheumatology Network.
We launched a special focus on the diagnosis of axial spondyloarthritis that included a summary of a study published in the New England Journal of Medicine that examined whether surgery is the better way to manage
We also featured an article from physicians writing in Mayo Clinic Proceedings who address factors that should be considered for an
And, this week we published a new column from Dr. Kim Gorgens, she is a Rheumatology Network board member and author of our
We also published two short stories on Rheumatoid Arthritis. One focuses on a study that proposes
And, in a second story on RA we featured a study that showed PRIME cells may serve as a




